GSK PLC GSK shares rose 1.78% to £13.72 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.42% to 9,061.49. GSK PLC ...

The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment, the company said on Wednesday.

As of June 30, the Fund held 46.2% in U.S. equities, 17.9% in non-U.S. equities, and 35.9% in fixed income securities plus ...

After strong multi-year performance in Financials, Dodge & Cox Global Stock Fund continued to steadily reduce its overweight position in the sector. Read more here.